keyword
MENU ▼
Read by QxMD icon Read
search

Hepatitis C in prison

keyword
https://www.readbyqxmd.com/read/27922518/hepatitis-c-point-of-care-testing-in-vulnerable-populations-a-human-factors-study
#1
Donna M Zucker, Akshaya Shanmugam
One third of all hepatitis C virus (HCV) cases in the United States are incarcerated in jails and prisons. Hepatitis C virus testing is primarily accomplished through a clinical laboratory, yet point-of-care (POC) testing is less invasive and results are available in 20 minutes compared with up to 3 weeks. The purpose of this article was to describe the findings of a collaborative project between the Colleges of Engineering and Nursing at the University of Massachusetts Amherst in executing a human factors study for HCV antibody testing and screening...
November 2016: Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates
https://www.readbyqxmd.com/read/27921633/healthcare-resources-are-inadequate-to-address-the-burden-of-illness-among-hiv-infected-male-prisoners-in-malaysia
#2
Joseph Bick, Gabriel Culbert, Haider A Al-Darraji, Clayton Koh, Veena Pillai, Adeeba Kamarulzaman, Frederick Altice
Purpose Criminalization of drug use in Malaysia has concentrated people who inject drugs (PWID) and people living with HIV into prisons where health services are minimal and HIV-related mortality is high. Few studies have comprehensively assessed the complex health needs of this population. The paper aims to discuss these issues. Design/methodology/approach From October 2012 through March 2013, 221 sequentially selected HIV-infected male prisoners underwent a comprehensive health assessment that included a structured history, physical examination, and clinically indicated diagnostic studies...
December 19, 2016: International Journal of Prisoner Health
https://www.readbyqxmd.com/read/27858889/correlates-of-infection-and-molecular-characterization-of-blood-borne-hiv-hcv-and-hbv-infections-in-hiv-1-infected-inmates-in-italy-an-observational-cross-sectional-study
#3
Nunzia Sanarico, Stefania D'Amato, Roberto Bruni, Claudia Rovetto, Emanuela Salvi, Patrizia Di Zeo, Paola Chionne, Elisabetta Madonna, Giulio Pisani, Angela Costantino, Michele Equestre, Maria E Tosti, Alessandra Cenci, Maria T Maggiorella, Leonardo Sernicola, Emanuele Pontali, Alfredo Pansera, Rocco Quattrocchi, Sergio Carbonara, Fabio Signorile, Lorenzo Antonio Surace, Guido Federzoni, Elisa Garlassi, Giulio Starnini, Roberto Monarca, Sergio Babudieri, Maria Rapicetta, Maria G Pompa, Anna Caraglia, Barbara Ensoli, Anna R Ciccaglione, Stefano Buttò
Coinfection of blood-borne hepatitis B and hepatitis C viruses (HBV and HCV, respectively) in human immunodeficiency virus type 1 (HIV-1)-positive individuals frequently occurs in inmate population and peculiar viral strains and patterns of virological markers may be observed.Plasma from 69 HIV-1-positive inmates was obtained from 7 clinical centers connected with correctional centers in different towns in Italy. HIV, HBV, and HCV markers were tested by commercial assays. Virus genotyping was carried out by sequencing the protease and reverse transcriptase-encoding region (PR-RT region) for HIV and a region encompassing the NS5B gene for HCV and subsequent phylogenetic analysis...
November 2016: Medicine (Baltimore)
https://www.readbyqxmd.com/read/27815935/are-the-testing-needs-of-key-european-populations-affected-by-hepatitis-b-and-hepatitis-c-being-addressed-a-scoping-review-of-testing-studies-in-europe
#4
REVIEW
Jeffrey V Lazarus, Ida Sperle, Alexander Spina, Jürgen K Rockstroh
AIM: To investigate whether or not key populations affected by hepatitis B and hepatitis C are being tested sufficiently for these diseases throughout the European region. METHODS: We searched MEDLINE and EMBASE for studies on HBV and HCV testing in the 53 Member States of the World Health Organization European Region following PRISMA criteria. RESULTS: 136 English-language studies from 24 countries published between January 2007 and June 2013 were found...
October 31, 2016: Croatian Medical Journal
https://www.readbyqxmd.com/read/27778436/social-capital-strategies-to-enhance-hepatitis-c-treatment-awareness-and-uptake-among-men-in-prison
#5
L Lafferty, C Treloar, J Guthrie, G M Chambers, T Butler
Prisoner populations are characterized by high rates of hepatitis C (HCV), up to thirty times that of the general population in Australia. Within Australian prisons, less than 1% of eligible inmates access treatment. Public health strategies informed by social capital could be important in addressing this inequality in access to HCV treatment. Twenty-eight male inmates participated in qualitative interviews across three correctional centres in New South Wales, Australia. All participants had recently tested as HCV RNA positive or were receiving HCV treatment...
October 24, 2016: Journal of Viral Hepatitis
https://www.readbyqxmd.com/read/27776593/epidemiological-study-of-hepatitis-b-virus-among-prisoners-with-active-tuberculosis-in-central-brazil
#6
L M M Iglecias, M A M Puga, M A Pompílio, S A Teles, J Croda, L A Lima, B V Lago, R M B Martins, A R C Motta-Castro
BACKGROUND: Due to environmental and social conditions inherent to incarceration, tuberculosis (TB) and hepatitis B virus (HBV) are major diseases among prison inmates. OBJECTIVE: To determine overall and occult HBV infection (OBI) prevalence rates, risk factors and genotype distribution among inmates with active TB. STUDY DESIGN: A cross-sectional study was conducted among 216 inmates with active TB recruited at the largest prisons in Campo Grande, Mato Grosso do Sul, Central Brazil...
November 2016: International Journal of Tuberculosis and Lung Disease
https://www.readbyqxmd.com/read/27774690/a-nurse-led-intervention-improved-blood-borne-virus-testing-and-vaccination-in-victorian-prisons
#7
Rebecca J Winter, Bethany White, Stuart A Kinner, Mark Stoové, Rebecca Guy, Margaret E Hellard
OBJECTIVES: Testing is the first step in treatment and care for blood-borne viruses (BBVs) and sexually transmitted infections (STIs). As new treatments for viral hepatitis emerge, it is important to document effective models for BBV/STI testing. A nurse-led intervention was implemented across three prisons in Victoria to improve BBV/STI testing. We evaluated the impact of the intervention on BBV/STI testing rates and hepatitis B (HBV) vaccination for reception prisoners. METHODS: BBV/STI testing and HBV vaccination data were collected from the medical files of 100 consecutive reception prisoners at three prisons (n=300) prior to and after the intervention was implemented...
December 2016: Australian and New Zealand Journal of Public Health
https://www.readbyqxmd.com/read/27755143/syphilis-hepatitis-c-and-hiv-in-eastern-europe
#8
Heather Bailey, Anna Turkova, Claire Thorne
PURPOSE OF REVIEW: Eastern Europe and Central Asia (EECA) has experienced large-scale epidemics of syphilis, hepatitis C virus (HCV) and HIV over the past few decades. Here, we review recent evidence on the epidemiology of and the response to these intersecting epidemics. RECENT FINDINGS: The HIV epidemic in EECA continues to expand, with new infections increasing by more than 50% between 2010 and 2015. HCV is now in the top 10 causes of death in EECA, with Russia accounting for more than half of the global burden of HCV infections, but access to direct-acting antivirals remains a major obstacle for control of the epidemic...
October 15, 2016: Current Opinion in Infectious Diseases
https://www.readbyqxmd.com/read/27702964/new-hepatitis-c-drugs-are-very-costly-and-unavailable-to-many-state-prisoners
#9
Adam L Beckman, Alyssa Bilinski, Ryan Boyko, George M Camp, A T Wall, Joseph K Lim, Emily A Wang, R Douglas Bruce, Gregg S Gonsalves
Prisoners bear much of the burden of the hepatitis C epidemic in the United States. Yet little is known about the scope and cost of treating hepatitis C in state prisons-particularly since the release of direct-acting antiviral medications. In the forty-one states whose departments of corrections reported data, 106,266 inmates (10 percent of their prisoners) were known to have hepatitis C on or about January 1, 2015. Only 949 (0.89 percent) of those inmates were being treated. Prices for a twelve-week course of direct-acting antivirals such as sofosbuvir and the combination drug ledipasvir/sofosbuvir varied widely as of September 30, 2015 ($43,418-$84,000 and $44,421-$94,500, respectively)...
October 1, 2016: Health Affairs
https://www.readbyqxmd.com/read/27694729/hbv-and-hcv-serological-monitoring-among-injection-drugs-users-in-opiate-substitution-treatment-in-bosnia-and-herzegovina
#10
Sinisa Skocibusic, Marko Martinac, Jurica Arapovic, Svjetlana Grgic, Jadranka Nikolic, Dino Hasanagic, Milenko Bevanda, Jelena Ravlija
INTRODUCTION: Use of intravenous heroin carries a risk of serious medical conditions, including acquiring blood-borne infections. Therefore, hepatitis B virus (HBV) and hepatitis C virus (HCV) infection represent a threat for people who inject drugs (PWID). The objectives of this study were to determine the extent and characteristics of risk factors for acquiring HBV and HCV infection in PWID included in opiate substitution treatment in the southern part of Bosnia and Herzegovina (B&H)...
September 30, 2016: Journal of Infection in Developing Countries
https://www.readbyqxmd.com/read/27672281/dried-blood-spots-valid-screening-for-viral-hepatitis-and-human-immunodeficiency-virus-in-real-life
#11
Belinda K Mössner, Benjamin Staugaard, Janne Jensen, Søren Thue Lillevang, Peer B Christensen, Dorte Kinggaard Holm
AIM: To detect chronic hepatitis B (CHB), chronic hepatitis C (CHC) and human immunodeficiency virus (HIV) infections in dried blood spot (DBS) and compare these samples to venous blood sampling in real-life. METHODS: We included prospective patients with known viral infections from drug treatment centers, a prison and outpatient clinics and included blood donors as negative controls. Five drops of finger capillary blood were spotted on filter paper, and a venous blood sample was obtained...
September 7, 2016: World Journal of Gastroenterology: WJG
https://www.readbyqxmd.com/read/27651805/prevalence-of-hepatitis-c-among-australian-aboriginal-and-torres-strait-islander-people-a-systematic-review-and-meta-analysis
#12
REVIEW
Simon Graham, Mary-Ellen Harrod, Jenny Iversen, Jane Simone Hocking
CONTEXT: Aboriginal and Torres Strait Islanders (Aboriginal) account for approximately 3% of the Australian population. They have the poorest health, economic and social outcomes. Higher notification rates of hepatitis C antibodies (anti-HCV) have been reported among Aboriginal compared with non-Aboriginal people. The identification of Aboriginal people in national surveillance has some weaknesses, with only four of the eight jurisdictions included in national reporting. To address some of these limitations, we aim to estimate the pooled prevalence of anti-HCV among Aboriginal people in Australia...
July 2016: Hepatitis Monthly
https://www.readbyqxmd.com/read/27617184/unlocking-dimensions-of-social-capital-in-the-prison-setting
#13
Lise Lafferty, Carla Treloar, Tony Butler, Jill Guthrie, Georgina M Chambers
BACKGROUND: Social capital has been shown to be a valuable resource for improving health outcomes. However, it has received little attention in the prison setting. Dimensions of social capital in mainstream society are likely to function differently among inmates in prison. This study seeks to identify and understand social capital dimensions among incarcerated men living with hepatitis C. METHODS: In-depth interviews were conducted across three correctional centres in New South Wales with 30 male inmates living with hepatitis C...
2016: Health & Justice
https://www.readbyqxmd.com/read/27601496/cost-effectiveness-of-screening-for-hepatitis-c-virus-a-systematic-review-of-economic-evaluations
#14
Stephanie Coward, Laura Leggett, Gilaad G Kaplan, Fiona Clement
OBJECTIVES: With the developments of near-cures for hepatitis C virus (HCV), who to screen has become a high-priority policy issue in many western countries. Cost-effectiveness of screening programmes should be one consideration when developing policy. The objective of this work is to synthesise the cost-effectiveness of HCV screening programmes. SETTING: A systematic review was completed. 5 databases were searched until May 2016 (NHSEED, MEDLINE, the HTA Health Technology Assessment Database, EMBASE, EconLit)...
2016: BMJ Open
https://www.readbyqxmd.com/read/27509844/a-matched-comparison-study-of-hepatitis-c-treatment-outcomes-in-the-prison-and-community-setting-and-an-analysis-of-the-impact-of-prison-release-or-transfer-during-therapy
#15
E J Aspinall, W Mitchell, J Schofield, A Cairns, S Lamond, P Bramley, S E Peters, H Valerio, J Tomnay, D J Goldberg, P R Mills, S T Barclay, A Fraser, J F Dillon, N K Martin, M Hickman, S J Hutchinson
Prisoners are a priority group for hepatitis C (HCV) treatment. Although treatment durations will become shorter using directly acting antivirals (DAAs), nearly half of prison sentences in Scotland are too short to allow completion of DAA therapy prior to release. The purpose of this study was to compare treatment outcomes between prison- and community-based patients and to examine the impact of prison release or transfer during therapy. A national database was used to compare treatment outcomes between prison treatment initiates and a matched community sample...
August 11, 2016: Journal of Viral Hepatitis
https://www.readbyqxmd.com/read/27506095/antiviral-treatment-of-hepatitis-c-in-serbian-prison-setting-medical-treatment-outcomes-and-patients-adherence
#16
Jasmina Simonović Babić, Ksenija Bojović, Dragan Delić, Nataga Katanić, Nikola Mitrović, Jovan Malinić
INTRODUCTION: Seroprevlence of chronic hepatitis C viral infection in correctional facilities ranges from 16% to 49%. However, there are only very limited data available on the course of hepatitis C viral infection and outcomes oftreatment with pegylated interferon plus ribavirin in correctional settings. The aim ofthis study was to assess the feasibility and effectiveness of use of pegylated interferon plus ribavirin treatment in the Serbian correctional setting. MATERIAL AND METHODS: The study sample consisted of the patients with hepatitis C hospitalized in the Special Hospital for Prisoners in Belgrade (Serbia) during 2007-2013...
March 2016: Medicinski Pregled
https://www.readbyqxmd.com/read/27486922/prison-officers-views-about-hepatitis-c-testing-and-treatment-a-qualitative-enquiry
#17
Kathryn Jack, Natalie Islip, Paul Linsley, Brian Thomson, Anne Patterson
AIMS AND OBJECTIVES: To explore the views of prison officers in an English category B male prison about people in prison being tested and treated for hepatitis C. BACKGROUND: Hepatitis C testing and treatment in English prisons remains low with the reasons being poorly understood. Prison officers are in continuous contact with prisoners so might observe factors that may influence people in prisons' choice in whether to accept hepatitis C testing and treatment. DESIGN: A qualitative design within an interpretative framework was employed...
August 3, 2016: Journal of Clinical Nursing
https://www.readbyqxmd.com/read/27453602/epidemiology-of-infectious-disease-related-death-after-release-from-prison-washington-state-united-states-and-queensland-australia-a-cohort-study
#18
Ingrid A Binswanger, Patrick J Blatchford, Simon J Forsyth, Marc F Stern, Stuart A Kinner
OBJECTIVES: People in prison may be at high risk for infectious diseases and have an elevated risk of death immediately after release compared with later; their risk of death is elevated for at least a decade after release. We compared rates, characteristics, and prison-related risk factors for infectious disease-related mortality among people released from prisons in Queensland, Australia, and Washington State, United States, regions with analogous available data. METHODS: We analyzed data from retrospective cohort studies of people released from prison in Queensland (1997-2007, n=37,180) and Washington State (1999-2009, n=76,208) and linked identifiers from each cohort to its respective national death index...
July 2016: Public Health Reports
https://www.readbyqxmd.com/read/27453598/performance-of-risk-based-and-birth-cohort-strategies-for-identifying-hepatitis-c-virus-infection-among-people-entering-prison-wisconsin-2014
#19
Lauren J Stockman, James Greer, Ryan Holzmacher, Beth Dittmann, Scott A Hoftiezer, Lori E Alsum, Audrey Prieve, Ryan P Westergaard, Sheila M Guilfoyle, James M Vergeront
OBJECTIVES: The prevalence of hepatitis C virus (HCV) infection among young adults is rising in Wisconsin. We examined the prevalence of HCV infection among male and female inmates entering two Wisconsin prisons and evaluated existing and alternate risk-based strategies for identifying HCV infection at intake. METHODS: We added HCV testing to the intake procedures for all 1,239 adults prison entrants at the Wisconsin Department of Corrections (WDOC) from November 3, 2014, to January 31, 2015...
July 2016: Public Health Reports
https://www.readbyqxmd.com/read/27427456/prevention-of-transmission-of-hiv-hepatitis-b-virus-hepatitis-c-virus-and-tuberculosis-in-prisoners
#20
REVIEW
Adeeba Kamarulzaman, Stewart E Reid, Amee Schwitters, Lucas Wiessing, Nabila El-Bassel, Kate Dolan, Babak Moazen, Andrea L Wirtz, Annette Verster, Frederick L Altice
The prevalence of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis are higher in prisons than in the general population in most countries worldwide. Prisons have emerged as a risk environment for these infections to be further concentrated, amplified, and then transmitted to the community after prisoners are released. In the absence of alternatives to incarceration, prisons and detention facilities could be leveraged to promote primary and secondary prevention strategies for these infections to improve prisoners health and reduce risk throughout incarceration and on release...
September 10, 2016: Lancet
keyword
keyword
79546
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"